As bacteria and fungi have been found to contain genes encoding enzymes that synthesize a plethora of potential secondary metabolites, interest has grown in the activation of these cryptic pathways.

Identification and overexpression of previously unknown genes associated with human disease is an important step toward developing new therapeutics. Current approaches rely on cloning and expressing ...